Harness the power of wastewater intelligence
We analyze sewage with molecular technologies and AI to provide early warning of population health threats across the globe.
We believe in the value of good data.
At Biobot, we’re harnessing the power of wastewater to predict disease clusters and outbreaks, optimize healthcare resources, and fuel breakthroughs in disease treatment. It’s all possible with good data – data that’s comparable across time and location – thanks to our robust methods and years of expertise.
Born at MIT, we’ve spent over a decade looking at wastewater as a measure for population health. We analyze wastewater to track the spread of respiratory illnesses like COVID-19, influenza, and RSV in real-time and on a national scale. We also monitor high-risk drug use, enabling effective and proactive harm reduction strategies and the prediction of potential overdose events.
Biobot’s data is more than just a snapshot. It’s a validated early warning system, proven to predict hospitalizations and pinpoint areas where healthcare resources are most needed. Researchers leverage our cutting-edge insights to develop new treatments, while public health officials strategically allocate resources based on our real-time data. Wastewater’s potential is vast, offering a reliable and predictive indicator of population health trends across a wide range of threats.
Wastewater data is the new frontier to understand population health outcomes
Representative
Wastewater data represents all members of a community that contribute to a sewage system, regardless of healthcare access.
Timely
Analyses published in peer-reviewed scientific journals have shown that Biobot’s wastewater data can detect viral surges in wastewater up to two full weeks before hospital admissions spike.
Accurate
Our SARS-CoV-2 data is strongly-correlated with COVID-19 cases. Our SARS-CoV-2 sequencing data from wastewater matches closely with clinical sequencing data.
The Biobot data advantage
Biobot’s data insights are industry leading (read more about it in Nature). We were the first company to commercialize wastewater-based epidemiology technology, and our foundations draw back to award-winning research at MIT. In 2021, Biobot was selected by the U.S. government to launch the first nationwide wastewater program for disease tracking, the CDC National Wastewater Surveillance System (NWSS).
Our data complements critical population health data sources
 | Publicly Available Wastewater Data | Publicly Available Hospitalization Data | Clinical Patient Data | |
| Inclusive of entire communities, not just those seeking medical care |  | |  | |
| Data comparability across entire U.S. and over periods of time | Facilitated by a single data collection & analysis method | Aggregates data from different labs using a variety of sample types, collection methods, and data analysis methods | |  Many disease areas do not require mandatory reporting of case data by providers |
| Data is timely and predictive of health trends | | | | |
| Single data source across viral disease areas and substance use disorder | | | | |
| Data interpretation & epidemiology support | | | | |
Unlock the Power of Wastewater Data
Gain early warnings on outbreaks, inform resource allocation, track population health trends, and understand community disease burden. See our data in action by requesting a demo below.